Vaccine News and Research

Latest Vaccine News and Research

Regulatory agencies offer marketing approval for new products to treat neglected diseases

New products to treat neglected diseases have received marketing approval from regulatory agencies at a steadily increasing rate in recent years as R&D funding for those diseases has increased, according to a recently completed study by the Tufts Center for the Study of Drug Development.

18 Nov 2009

Previous flu infections can reduce the severity of H1N1

Researchers at the La Jolla Institute for Allergy & Immunology have found that previous influenza infections may provide at least some level of immunity to the H1N1 "swine" flu. "The question we asked was, "Is the swine flu more like the seasonal flu or like a totally new strain of influenza where there would be no immunity?," said Alessandro Sette, Ph.D., an internationally recognized vaccine expert and director of the La Jolla Institute's Center for Infectious Disease.

18 Nov 2009

Cinergy Health creates a guide for the prevention and treatment of H1N1

Cinergy Health, a nationwide provider of guaranteed issue health insurance benefit programs, has created a guide for consumers concerned about the H1N1 virus, which has already killed more than 4,000 Americans.

18 Nov 2009

China, WHO to collaborate on flu research center

Chinese and WHO officials last week agreed to open a flu research center in Beijing, Bloomberg reports. "The new collaborating center for reference and research on influenza will join a network of WHO-affiliated labs in Atlanta, London, Tokyo and Melbourne that monitor flu strains and make recommendations on vaccines to fight the virus," the news service writes

17 Nov 2009

Also in global health news: Global corruption; HIV vaccine; smoking; DRC aid

A new report from Transparency International says the fight against corruption worldwide is slowing as urgency to address the global economic downturn recedes, Bloomberg reports.

17 Nov 2009

Bavarian Nordic awarded a new contract for developing a freeze-dried version of its IMVAMUNE smallpox vaccine

Bavarian Nordic A/S announced today that BARDA (Biomedical Advanced Research and Development Authority) has awarded a new contract to Bavarian Nordic for the development of a freeze-dried version of its IMVAMUNE(R) smallpox vaccine with a total prospective value of USD 40 million.

17 Nov 2009

Total of 1,686,100 doses of H1N1 vaccine allocated to Pennsylvania to date: Department of Health

The federal Centers for Disease Control and Prevention, or CDC, has allocated a total of 1,686,100 doses of H1N1 vaccine to Pennsylvania to date, the Department of Health said today.

17 Nov 2009

Molecular makeup of current H1N1 flu strain strikingly different from previous H1N1 strains

As the number of deaths related to the pandemic H1N1 virus, commonly known as "swine flu," continues to rise, researchers have been scrambling to decipher its inner workings and explain why the incidence is lower than expected in older adults.

17 Nov 2009

Trustmark Voluntary Benefit Solutions offers coverage for vaccines including H1N1 to its policyholders

Trustmark Voluntary Benefit Solutions, a leading provider of payroll-deducted voluntary benefits, is now covering vaccines including H1N1 (swine flu).

17 Nov 2009

BioSante Pharmaceuticals applauds Boehringer Ingelheim for developing a therapy to treat HSDD

BioSante Pharmaceuticals, Inc., a specialty pharmaceutical company developing products for female sexual health, including LibiGel® for the treatment of hypoactive sexual desire disorder (HSDD), applauds the efforts of Boehringer Ingelheim to develop a therapy to treat this unmet medical need.

17 Nov 2009

Targeting normal cells that surround cancer cells increases the effectiveness of traditional anti-cancer treatments

Targeting the normal cells that surround cancer cells within and around a tumor is a strategy that could greatly increase the effectiveness of traditional anti-cancer treatments, say researchers at The Wistar Institute.

17 Nov 2009

FDA approves CSL's seasonal and H1N1 flu vaccines for children

The U.S. Food and Drug Administration has approved the use of the CSL Limited's seasonal and 2009 H1N1 influenza vaccines to include children ages 6 months and older. These vaccine were previously approved for use in adults, ages 18 years and older

17 Nov 2009

Scientists find major genetic differences between the pandemic H1N1 strain and seasonal strains

17 Nov 2009

Targeted Genetics announces third quarter 2009 results; reports net income of $0.03 per common share

Targeted Genetics Corporation today announced its financial results for the third quarter ended September 30, 2009.

17 Nov 2009

Handwashing: A simple, effective way to prevent the spread of communicable diseases

In this day and age, with the latest in medical equipment and scientific advances adding both quantity and quality to our lives, it is easy to forget that the simplest actions can provide some of the most important results. In fact, your mother's instructions to "wash up before dinner" should be considered some of the soundest medical advice ever offered.

17 Nov 2009

Additional vaccine for 2009 H1N1 flu approved by FDA

The U.S. Food and Drug Administration announced that it has approved a fifth vaccine for protection against the 2009 H1N1 influenza virus. The vaccine is manufactured by ID Biomedical Corp. of Quebec, Canada, owned by GlaxoSmithKline PLC.

16 Nov 2009

Erbitux recognized as one of the major clinical cancer advances of 2009

The American Society of Clinical Oncology (ASCO) has once again recognized Erbitux® (cetuximab) as one of the major clinical cancer advances of 2009. This year Erbitux was selected by ASCO for providing the first significant increase in survival for 30 years in the treatment of patients with 1st-line recurrent and/or metastatic squamous cell carcinoma of the head and neck (SCCHN).

16 Nov 2009

Macomb County targets pregnant women and health care workers for its next two H1N1 vaccine clinics

Pregnant women, their families and health care workers are being targeted by the Macomb County Health Department for its next two H1N1 vaccine clinics, department officials announced today. All are being offered at no charge.

16 Nov 2009

Inovio Biomedical reports financial results for the three and nine months ended September 30, 2009

Inovio Biomedical Corporation today reported financial results for the three and nine months ended September 30, 2009.

16 Nov 2009

Hope for vaccine against Chlamydia

"Now that we know how the body defends itself against the Chlamydia bacteria, we can develop a vaccine that optimises that defence. We have a basic understanding of how the vaccine could work, but some work remains to be done. We believe that it will take a few years before the vaccine becomes a reality," says researcher Ellen Marks, the author of the thesis.

16 Nov 2009

Vaccine News and Research

Latest Vaccine News and Research

Regulatory agencies offer marketing approval for new products to treat neglected diseases

Previous flu infections can reduce the severity of H1N1

Cinergy Health creates a guide for the prevention and treatment of H1N1

China, WHO to collaborate on flu research center

Also in global health news: Global corruption; HIV vaccine; smoking; DRC aid

Bavarian Nordic awarded a new contract for developing a freeze-dried version of its IMVAMUNE smallpox vaccine

Total of 1,686,100 doses of H1N1 vaccine allocated to Pennsylvania to date: Department of Health

Molecular makeup of current H1N1 flu strain strikingly different from previous H1N1 strains

Trustmark Voluntary Benefit Solutions offers coverage for vaccines including H1N1 to its policyholders

BioSante Pharmaceuticals applauds Boehringer Ingelheim for developing a therapy to treat HSDD

Targeting normal cells that surround cancer cells increases the effectiveness of traditional anti-cancer treatments

FDA approves CSL's seasonal and H1N1 flu vaccines for children

Scientists find major genetic differences between the pandemic H1N1 strain and seasonal strains

Targeted Genetics announces third quarter 2009 results; reports net income of $0.03 per common share

Handwashing: A simple, effective way to prevent the spread of communicable diseases

Additional vaccine for 2009 H1N1 flu approved by FDA

Erbitux recognized as one of the major clinical cancer advances of 2009

Macomb County targets pregnant women and health care workers for its next two H1N1 vaccine clinics

Inovio Biomedical reports financial results for the three and nine months ended September 30, 2009

Hope for vaccine against Chlamydia

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in